![Automated and Manual Quantification of Tumour Cellularity in Digital Slides for Tumour Burden Assessment | Scientific Reports Automated and Manual Quantification of Tumour Cellularity in Digital Slides for Tumour Burden Assessment | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-50568-4/MediaObjects/41598_2019_50568_Fig1_HTML.png)
Automated and Manual Quantification of Tumour Cellularity in Digital Slides for Tumour Burden Assessment | Scientific Reports
![Cancers | Free Full-Text | Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity Cancers | Free Full-Text | Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity](https://www.mdpi.com/cancers/cancers-13-02492/article_deploy/html/images/cancers-13-02492-g004.png)
Cancers | Free Full-Text | Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity
Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy | PLOS ONE
![Stefania Landolfi on Twitter: "Residual Cancer Burden evaluation in post-NAST #Breastpath #USCAP2018 #insitupathologists https://t.co/4GSxTI47S5" / Twitter Stefania Landolfi on Twitter: "Residual Cancer Burden evaluation in post-NAST #Breastpath #USCAP2018 #insitupathologists https://t.co/4GSxTI47S5" / Twitter](https://pbs.twimg.com/media/DYlT9WBVoAA6vFS.jpg)
Stefania Landolfi on Twitter: "Residual Cancer Burden evaluation in post-NAST #Breastpath #USCAP2018 #insitupathologists https://t.co/4GSxTI47S5" / Twitter
![Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapy - ScienceDirect Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419313481-gr1.jpg)
Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapy - ScienceDirect
![December 10-14, 2013 An Update on Breast Cancer CCO Independent Conference Coverage of the 2013 Annual Meeting of the CTRC-AACR San Antonio Breast Cancer. - ppt download December 10-14, 2013 An Update on Breast Cancer CCO Independent Conference Coverage of the 2013 Annual Meeting of the CTRC-AACR San Antonio Breast Cancer. - ppt download](https://images.slideplayer.com/47/11712761/slides/slide_68.jpg)
December 10-14, 2013 An Update on Breast Cancer CCO Independent Conference Coverage of the 2013 Annual Meeting of the CTRC-AACR San Antonio Breast Cancer. - ppt download
![Cancers | Free Full-Text | Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity Cancers | Free Full-Text | Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity](https://www.mdpi.com/cancers/cancers-13-02492/article_deploy/html/images/cancers-13-02492-g001.png)
Cancers | Free Full-Text | Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity
![Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology](https://www.thelancet.com/cms/attachment/aebe7284-f489-4fa5-a13d-db5ed5bcba73/gr2_lrg.jpg)
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
![Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype | Journal of Clinical Oncology Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2017/jco.2017.35.issue-10/jco.2015.63.1010/20171010/images/large/jco.2015.63.1010t3.jpeg)
Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype | Journal of Clinical Oncology
![Frontiers | Improved Prediction of Survival Outcomes Using Residual Cancer Burden in Combination With Ki-67 in Breast Cancer Patients Underwent Neoadjuvant Chemotherapy Frontiers | Improved Prediction of Survival Outcomes Using Residual Cancer Burden in Combination With Ki-67 in Breast Cancer Patients Underwent Neoadjuvant Chemotherapy](https://www.frontiersin.org/files/MyHome%20Article%20Library/903372/903372_Thumb_400.jpg)
Frontiers | Improved Prediction of Survival Outcomes Using Residual Cancer Burden in Combination With Ki-67 in Breast Cancer Patients Underwent Neoadjuvant Chemotherapy
![Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy | Modern Pathology Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy | Modern Pathology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fmodpathol.2015.53/MediaObjects/41379_2015_Article_BFmodpathol201553_Fig3_HTML.jpg)
Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy | Modern Pathology
![A) Distribution of residual cancer burden (RCB) scores (means). (B)... | Download Scientific Diagram A) Distribution of residual cancer burden (RCB) scores (means). (B)... | Download Scientific Diagram](https://www.researchgate.net/profile/Christos-Hatzis/publication/23137803/figure/tbl1/AS:670319907979264@1536828128049/Patient-and-tumor-characteristics-a_Q320.jpg)
A) Distribution of residual cancer burden (RCB) scores (means). (B)... | Download Scientific Diagram
![Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy | Modern Pathology Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fmodpathol.2015.53/MediaObjects/41379_2015_Article_BFmodpathol201553_Fig1_HTML.jpg)
Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy | Modern Pathology
![Good practice: The experiences with the utilization of residual cancer burden—A single institution study - Sejben - Thoracic Cancer - Wiley Online Library Good practice: The experiences with the utilization of residual cancer burden—A single institution study - Sejben - Thoracic Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/56a455f6-dc53-41ae-9731-deb005c0d70f/tca.v14.7.cover.jpg)
Good practice: The experiences with the utilization of residual cancer burden—A single institution study - Sejben - Thoracic Cancer - Wiley Online Library
![A scoping review of interactive and personalized web-based clinical tools to support treatment decision making in breast cancer - The Breast A scoping review of interactive and personalized web-based clinical tools to support treatment decision making in breast cancer - The Breast](https://www.thebreastonline.com/cms/asset/b4c9d307-60a2-407a-b21d-bf17e5c213f5/gr1.jpg)
A scoping review of interactive and personalized web-based clinical tools to support treatment decision making in breast cancer - The Breast
![Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology](https://www.thelancet.com/cms/attachment/34b2410d-db54-46e1-ac1d-1d1894292938/gr1_lrg.gif)